A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2006
11/07/2006	US7132435 Syn-1H-indazole-3-carboxylic acid (4-{[2-(2,3-dihydro-benzo[b]thiophen-6-yloxy)-5-fluoro-pyridine-3-carbonyl]amino}-cyclohexyl)-amide; useful as cyclic nucleotide phosphodiesterase-4 ( PDE-4 ) inhibitor
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132399 Mammalian cell surface DNA receptor
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132246 Use of soluble cytokeratin-1-fragments in diagnostics and therapy
11/07/2006	CA2375093C Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/02/2006	WO2006116563A1 Vanilloid receptor ligands and their use in treatments
11/02/2006	WO2006115452A1 Use of pyrazolyl-pyrimidine derivatives in the treatment of pain
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115187A1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/02/2006	WO2006115168A1 N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same
11/02/2006	WO2006115130A1 Calcium bis[(2s)-3-[3-[(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy]phenyl]-2-isopropoxypropionate] and intermediate thereof
11/02/2006	WO2006113981A2 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method
11/02/2006	WO2006086500A3 Compositions and methods for treating vascular, autoimmune and inflammatory diseases
11/02/2006	WO2006086498A3 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
11/02/2006	WO2005113515A8 Pyrimidines for use as plk inhibitors
11/02/2006	WO2005107748A3 Method of tonic treatment with oxyphenbutazone derivatives
11/02/2006	WO2005086814A3 Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (gsk-3)
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247307 imino compound as antiinflammatory agent, anticarcinogenic agent for treating chronic inflammation and cancers; activating peroxisome proliferator-activated receptor
11/02/2006	US20060247297 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247269 Thienopyridone derivatives as kinase inhibitors
11/02/2006	US20060247268 N-sulfonylaminothiazole
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247257 Combination
11/02/2006	US20060247251 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/02/2006	US20060247241 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247183 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	US20060243276 Methods for treating rhinitis and conjunctivitis
11/02/2006	EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1717224A1 Peptidyl arginine deiminase type iv inhibitor
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716868A1 Anti-inflammatory analgesic for external use
11/02/2006	EP1716855A1 Remedy for external use for skin and mucosal injuries caused by viral infection
11/02/2006	EP1716854A1 External preparation for treating painful skin wound
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716151A1 Compositions useful as inhibitors of protein kinases
11/02/2006	EP1716146A1 Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
11/02/2006	EP1716134A1 Amino heterocyclic modulators of chemokine receptor activity
11/02/2006	EP1715876A1 New synbiotic use
11/02/2006	EP1715862A1 Kinase inhibitors
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	EP1250313B1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl\|cyclohexanecarboxylate
11/02/2006	EP1219596B1 Salicylamide derivatives
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1102589B1 Topical compositions comprising an opioid analgesic and an nmda antagonist
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	DE102005020331A1 New 5-substituted quinoline and isoquinoline derivatives are glucocorticoid receptor binders useful for treating inflammatory diseases e.g. alveolitis, Sjogren's syndrome, atopic dermatitis, acute lymphatic leukemia, rhinitis and emesis
11/02/2006	DE102005018025A1 New heterocyclic compounds which are cytokine interleukin-8 inhibitors useful for treating e.g., chronic obstructive lung disease, bronchitis, rheumatoid arthritis, psoriasis, gastrointestinal disease and Crohn's disease
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605351A1 N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same
11/02/2006	CA2605331A1 Calcium bis[(2s)-3-[3-[(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy]phenyl]-2-isopropoxypropionate] and intermediate thereof
11/01/2006	CN1856495A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856494A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856493A Aminopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856492A Imidazo(4,5-B)pyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856491A Imidazopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/01/2006	CN1856467A 2-pyridone derivatives as netrophil elastase inhibitors and their use.
11/01/2006	CN1856314A Farmaceutiske kombinationer af adenosin A-2a- og beta-2-adrenerge receptoragonister
11/01/2006	CN1856309A Hexa- and octahydro-pyrido[1,2-a] pyrazine derivatives with NK1 antagonistic activity
11/01/2006	CN1853728A Method prescription and use for improving medicine or nutrient oral absorption
11/01/2006	CN1853679A Medicinal composition for treating cervical spondylosis and preparation thereof
11/01/2006	CN1853663A Analgesic
11/01/2006	CN1853651A Medicinal composition containing cinnabar or/and realgar
11/01/2006	CN1853615A Tablet containing brufen and producing process thereof
11/01/2006	CN1282480C Head ache capsule preparation
11/01/2006	CN1282456C Paroxetine control-released composite
11/01/2006	CN1282452C Use of aminoadamantane compound as immunoregulators
10/2006
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129272 Apoptosis inhibitor
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129253 Compounds
10/31/2006	US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use

1 ... 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 ... 1272